SUPN
NASDAQ · Pharmaceuticals
Supernus Pharmaceuticals Inc
$50.06
+0.68 (+1.38%)
Performance
1D
—
1W
—
1M
—
3M
-2.93%
6M
+5.17%
1Y
+54.84%
YTD
+1.19%
Open$50.01
Previous Close$49.38
Day High$50.78
Day Low$49.81
52W High$59.68
52W Low$29.16
Volume—
Avg Volume1.12M
Market Cap3.06B
P/E Ratio—
EPS$-0.68
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$49.76
Above
SMA 200
$43.00
Above
RSI (14)
59.9
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
12 analysts
Price Target
+81.4% upside
Current
$50.06
$50.06
Target
$90.83
$90.83
$64.19
$90.83 avg
$118.96
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 728.21M | 710.31M | 1.12B |
| Net Income | -39,046,923 | -34,278,414 | 218.96M |
| Profit Margin | -5.4% | -5.1% | 19.5% |
| EBITDA | 27.53M | 25.51M | 345.29M |
| Free Cash Flow | — | — | 147.80M |
| Rev Growth | +2.5% | +2.5% | +10.9% |
| Debt/Equity | — | — | 0.45 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |